A phase I study of SU5416 [semaxanib] in combination with gemcitabine/cisplatin in patients with advanced solid tumors

Trial Profile

A phase I study of SU5416 [semaxanib] in combination with gemcitabine/cisplatin in patients with advanced solid tumors

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Sep 2005

At a glance

  • Drugs Semaxanib (Primary) ; Cisplatin; Gemcitabine
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top